Table 2.
MESA | CHS | |||||
---|---|---|---|---|---|---|
HR (95% CI) | HR (95% CI) | |||||
n | Demographic Adjusteda |
Fully Adjustedb | n | Demographic Adjusteda |
Fully Adjustedb | |
All-cause mortalityc | ||||||
GFR not decreased | 5759 | 1.00 (ref) | 1.00 (ref) | 3639 | 1.00 (ref) | 1.00 (ref) |
decreased GFRcreat only | 614 | 0.76 (0.48, 1.20) | 0.80 (0.50, 1.26) | 605 | 1.10 (0.98, 1.22) | 1.09 (0.98, 1.21) |
decreased GFRcys only | 107 | 3.43 (1.96, 5.98) | 3.23 (1.84, 5.67) | 227 | 1.94 (1.67, 2.25) | 1.78 (1.53, 2.08) |
decreased GFR both | 269 | 1.97 (1.31, 2.96) | 1.93 (1.27, 2.92) | 689 | 1.96 (1.78, 2.16) | 1.74 (1.58, 1.93) |
Cardiovascular diseased | ||||||
GFR not decreased | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | 1.00 (ref) | ||
decreased GFRcreat only | 1.18 (0.78, 1.78) | 1.22 (0.80, 1.85) | 1.13 (0.99, 1.29) | 1.05 (0.92, 1.20) | ||
decreased GFRcys only | 2.22 (1.13, 4.39) | 1.92 (0.97, 3.82) | 1.83 (1.52, 2.21) | 1.52 (1.26, 1.84) | ||
decreased GFR both | 2.07 (1.32, 3.24) | 1.67 (1.06, 2.63) | 1.86 (1.65, 2.09) | 1.46 (1.29, 1.65) | ||
Heart failuree | ||||||
GFR not decreased | 1.00 (ref) | 1.00 (ref) | ||||
decreased GFRcreat only | 1.08 (0.91, 1.27) | 0.99 (0.84, 1.18) | ||||
decreased GFRcys only | 2.12 (1.68, 2.66) | 1.69 (1.33, 2.13) | ||||
decreased GFR both | 1.91 (1.64, 2.23) | 1.43 (1.22, 1.67) | ||||
Kidney failuref | ||||||
GFR not decreased | 1.00 (ref) | 1.00 (ref) | ||||
decreased GFRcreat only | 2.67 (1.03, 6.90) | 2.60 (1.00, 6.75) | ||||
decreased GFRcys only | 7.69 (2.78, 21.25) | 6.14 (2.18, 17.29) | ||||
decreased GFR only | 30.95 (17.0, 56.34) | 23.82 (12.68, 44.76) |
ref, referent group.
Adjusted for age, race, and gender.
Adjusted for age, race, gender, diabetes, hypertension, LDL, HDL, CRP, and prevalent CVD for CHS (persons with baseline CVD were excluded for incident CVD analyses).
223 deaths for MESA and 3345 deaths for CHS.
212 events for MESA and 2249 events for CHS.
1407 events for CHS.
84 events for CHS.